For example, CLIC1-expressing pancreatic cancer patients undergo to a worse overall survival as compared with patients developing CLIC1-negative tumors [9]; CLIC1 upregulation is correlated to chemotherapy resistance in ovarian cancer, [10], and with clinical aggressiveness and metastatic diffusion in colorectal cancer [11]. This evidence concerns the gene CLIC1 and pancreatic neoplasm.